Cargando…
Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation
BACKGROUND: Epigenetic reprogramming reportedly has a crucial role in prostate cancer (PCa) progression. RNA modification is a hot topic in epigenetics, and N6-methyladenosine (m6A) accounts for approximately 60% of RNA chemical modifications. The aim of this study was to evaluate the m6A modificati...
Autores principales: | Quan, Yongjun, Zhang, Xiaodong, Ping, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772220/ https://www.ncbi.nlm.nih.gov/pubmed/35045837 http://dx.doi.org/10.1186/s12935-021-02438-1 |
Ejemplares similares
-
Histone lysine methylation patterns in prostate cancer microenvironment infiltration: Integrated bioinformatic analysis and histological validation
por: Quan, Yongjun, et al.
Publicado: (2022) -
Identification of novel key genes associated with the metastasis of prostate cancer based on bioinformatics prediction and validation
por: Song, Feifeng, et al.
Publicado: (2021) -
Identification of aberrantly methylated differentially expressed genes in prostate carcinoma using integrated bioinformatics
por: Wu, Kai, et al.
Publicado: (2019) -
Identification and validation of m(6)A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer
por: Wang, Xinyi, et al.
Publicado: (2020) -
The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma
por: Yu, Zhi-Hao, et al.
Publicado: (2021)